About Natera
Industry:
Diagnostics
Founded:
2004
Founders:
Matthew Rabinowitz
Status:
Public (NASDAQ: NTRA)
Funding & Growth
Total Raised:
$600M+
Valuation:
$15B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • Leader in NIPT and prenatal testing
- • Growing oncology (Signatera) business
- • Strong growth trajectory
- • Austin, TX location
- • Meaningful clinical impact
✗ Cons
- • Fast-paced, demanding environment
- • Some work-life balance challenges
- • Competitive diagnostics market
- • Reimbursement challenges